SVA NASDAQ
Sinovac Biotech Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
$6.47
Last traded 2025-03-10 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$13.7B
-3.2% ▼
5Y CAGR: +105.8%
Total Liabilities
$1.6B
+16.6% ▲
5Y CAGR: +83.8%
Shareholders Equity
$8.7B
-2.4% ▼
5Y CAGR: +102.9%
Cash & Investments
$11.2B
-0.8% ▼
5Y CAGR: +129.3%
Total Debt
$299M
+300.4% ▲
5Y CAGR: +84.7%
Net Debt
-$971M
+76.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $153M | $1.0B | $11.6B | $4.3B | $1.3B |
| Short-Term Investments | $50M | $135M | $1.8B | $7.0B | $10.0B |
| Cash & ST Investments | $203M | $1.2B | $13.4B | $11.3B | $11.2B |
| Net Receivables | $114M | $253M | $952M | $609M | $451M |
| Inventory | $28M | $106M | $376M | $181M | $140M |
| Other Current Assets | $3M | $9M | $11M | $8M | $5M |
| Total Current Assets | $350M | $1.6B | $14.9B | $12.1B | $11.8B |
| Property, Plant & Equip. | $83M | $304M | $1.1B | $1.2B | $1.0B |
| Goodwill & Intangibles | $8M | $10M | $41M | $80M | $9M |
| Long-Term Investments | $0 | $7M | $656M | $661M | $684M |
| Other Non-Current Assets | $23K | -$7M | $25K | $3M | $73M |
| Total Non-Current Assets | $103M | $341M | $1.8B | $2.0B | $1.8B |
| Total Assets | $452M | $1.9B | $16.7B | $14.1B | $13.7B |
| — Liabilities — | |||||
| Accounts Payable | $6M | $31M | $59M | $20M | $17M |
| Short-Term Debt | $13M | $39M | $5M | $5M | $76M |
| Deferred Revenue | $8M | $379M | $92M | $33M | $20M |
| Other Current Liabilities | $100M | $326M | $1.3B | $1.6B | $343M |
| Total Current Liabilities | $87M | $680M | $2.4B | $1.1B | $1.1B |
| Long-Term Debt | $1M | $8M | $17M | $12M | $178M |
| Other Non-Current Liab. | $2M | $865K | $444K | $240K | $439K |
| Total Non-Current Liabilities | $13M | $102M | $459M | $310M | $487M |
| Total Liabilities | $100M | $781M | $2.9B | $1.4B | $1.6B |
| — Equity — | |||||
| Common Stock | $99K | $99K | $100K | $100K | $100K |
| Retained Earnings | $57M | $144M | $7.1B | $7.2B | $7.1B |
| Accumulated OCI | $29M | $70M | $1.6B | $1.2B | $1.0B |
| Total Stockholders Equity | $294M | $746M | $9.3B | $8.9B | $8.7B |
| Total Liabilities & Equity | $452M | $1.9B | $16.7B | $14.1B | $13.7B |
| — Key Metrics — | |||||
| Total Debt | $20M | $136M | $145M | $75M | $299M |
| Net Debt | -$132M | -$905M | -$11.5B | -$4.2B | -$971M |
| Total Investments | $50M | $142M | $2.5B | $7.7B | $10.6B |